Co-Diagnostics， Inc.将在华盛顿特区举办的第17届下一代诊断峰会上设立展位-动脉网

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

CISION 等信源发布 2025-08-18 21:30



可切换为仅中文







SALT LAKE CITY

盐湖城

，

Aug. 18, 2025

2025年8月18日

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq:

/PRNewswire/ -- Co-Diagnostics, Inc.（纳斯达克：

CODX

) (the 'Company' or 'Co-Dx'), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it will be hosting a booth at the 17

)（“公司”或“Co-Dx”），一家拥有独特且获得专利的分子诊断测试开发平台的分子诊断公司，今天宣布将设立一个展台参加第17届。

Annual Next Generation Dx Summit, held virtually and in-person at the Capital Hilton in

每年一度的下一代诊断峰会，虚拟和现场在首都希尔顿酒店举行。

Washington, D.C.

华盛顿特区

打开

August 18-20, 2025

2025年8月18日至20日

。

Cambridge Healthtech Institute's Next Generation Dx Summit is described as the nexus for international thought leaders to network and discuss diagnostic advancement and technology innovation, and offers a valuable window into how point-of-care,

剑桥健康技术研究所的下一代诊断峰会被描述为国际思想领袖交流和讨论诊断进展与技术创新的中心，提供了了解即时检验、

decentralized

去中心化的

testing, infectious disease, liquid biopsy and companion diagnostics are improving the standard of care in the diagnostics industry.

检测、传染病、液体活检和伴随诊断正在提高诊断行业的护理标准。

Attendees are invited to visit the Company at Booth #12 to learn more about the Co-Dx Logix Smart® suite of clinical laboratory solutions, as well as the upcoming Co-Dx PCR diagnostics platform* and the pipeline of upper respiratory, tuberculosis and HPV tests, all of which the Company is anticipating entering into clinical evaluations during 2025..

参观者受邀前往12号展位了解公司推出的Co-Dx Logix Smart®系列临床实验室解决方案，以及即将推出的Co-Dx PCR诊断平台*和上呼吸道、结核病及HPV检测产品线，公司预计所有这些产品将在2025年进入临床评估阶段。

To learn more about the summit, including in-person and virtual registration details, please visit

要了解更多关于峰会的信息，包括现场和虚拟注册详情，请访问

https://www.nextgenerationdx.com

。

Company travel and conference attendance is made possible due in part to a grant from

公司旅行和参加会议的部分资金由以下来源提供：

World Trade Center Utah

犹他州世界贸易中心

, a member of the World Trade Centers Association founded in 2006 with the goal of helping

，世界贸易中心协会的成员，成立于2006年，旨在帮助

Utah

犹他州

companies increase revenue and create jobs by expanding international sales, attracting foreign investment, and facilitating international partnerships.

公司通过扩大国际销售、吸引外国投资以及促进国际合作来增加收入和创造就业机会。

*The Co-Dx PCR platform (including the Co-Dx PCR Home™, Co-Dx PCR Pro™, mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is not available for sale.

*Co-Dx PCR平台（包括Co-Dx PCR Home™、Co-Dx PCR Pro™、移动应用程序及所有相关测试和软件）需经FDA和/或其他监管机构审查，目前尚未上市销售。

About Co-Diagnostics, Inc.:

关于Co-Diagnostics公司：

Co-Diagnostics, Inc., a

科迪agnostics公司，一家

Utah

犹他州

corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to identify genetic markers for use in applications other than infectious disease..

公司是一家分子诊断公司，致力于开发、制造和销售最先进的诊断技术。公司技术用于设计检测和/或分析核酸分子（DNA或RNA）的测试。公司还利用其专有技术为其Co-Dx PCR家用和即时诊断平台设计特定测试，并识别遗传标记，用于传染性疾病以外的应用。

SOURCE Co-Diagnostics

来源：Co-Diagnostics

WANT YOUR COMPANY'S NEWS

希望贵公司的新闻

FEATURED ON PRNEWSWIRE.COM?

荣登PRNEWSWIRE.COM？

440k+

44万+

Newsrooms &

新闻编辑室 &

Influencers